Since previous research has shown that TIE2 could directly induce the dormancy of hematopoietic stem cells and prostate cancer cells in vitro, we wanted to investigate first the clinical relevance of TIE2 expression in cancer progression [19,20]. This evidence concerns the gene TEK and prostate carcinoma.